Clinical Trials Sponsored by Jaeb Center for Health Research

Total 10341 results

Jaeb Center for Health Research

Recruiting

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Cystic Fibrosis

United States
Jaeb Center for Health Research

Completed

Virtual Diabetes Specialty Clinic: A Study Evaluating Remote Initiation of Continuous Glucose Monitoring (VDiSC)

Type 1 Diabetes | Type 2 Diabetes

United States
Jaeb Center for Health Research

Terminated

Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes

Type 1 Diabetes

United States
Jaeb Center for Health Research

Completed

Inpatient Evaluation of an Automated Closed-Loop Control-to-Range System (CTR)

Type 1 Diabetes

United States, France, Israel, Italy
Jaeb Center for Health Research

Completed

DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME (DRCR AC)

Diabetic Macular Edema

United States
Jaeb Center for Health Research

Completed

Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use (CTR3)

Type 1 Diabetes

United States, France, Israel, Italy
Jaeb Center for Health Research

Completed

A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes (REPLACE-BG)

Type 1 Diabetes

United States
Insulet Corporation
Jaeb Center for Health Research

Completed

OP5-005 Using Omnipod 5 in Adults With Type 2 (SECURE-T2D)

Type2 Diabetes

United States
DexCom, Inc.
Jaeb Center for Health Research

Completed

Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE) (MOBILE)

Diabetes Mellitus, Type 2

United States
Jaeb Center for Health Research
DexCom, Inc.

Completed

Time in Glucose Hospital Target (TIGHT)

Diabetes Mellitus, Type 2

United States
Mannkind Corporation
Jaeb Center for Health Research

Active, not recruiting

INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

Diabetes Mellitus, Type 1

United States
DexCom, Inc.
Jaeb Center for Health Research

Completed

Assessing Non-adjunctive CGM Safety at Home and in New Markets (ANSHIN)

Diabetes Mellitus

United States
Jaeb Center for Health Research
Xeris Pharmaceuticals

Completed

The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

Diabetes Mellitus, Type 1

United States
Jaeb Center for Health Research
Xeris Pharmaceuticals

Completed

Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia

Diabetes Mellitus, Type 1

United States
DexCom, Inc.
Jaeb Center for Health Research

Completed

Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes (DIaMonD)

Diabetes Mellitus

United States, Canada
Mannkind Corporation
Jaeb Center for Health Research

Active, not recruiting

Afrezza® INHALE-1 Study in Pediatrics (INHALE-1)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
DexCom, Inc.
Jaeb Center for Health Research

Completed

Evaluation of Modified Adhesives With Dexcom G6 Sensor

Diabetes

United States
Jaeb Center for Health Research
Foundation Fighting Blindness

Active, not recruiting

Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A)

Usher Syndrome, Type 2A | Retinitis Pigmentosa 39

United States, Canada, France, Germany, Netherlands, United Kingdom
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation

Completed

Insulin Clamp Ancillary Study for Assessment of Insulin Resistance

Type 1 Diabetes

United States
Nemours Children's Clinic
Jaeb Center for Health Research

Recruiting

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

Diabetes Mellitus, Type 1 | Child | Delivery of Health Care | Equipment and Supplies

United States
Bigfoot Biomedical Inc.
Jaeb Center for Health Research

Enrolling by invitation

Bigfoot Unity Real World Study (BURST)

Type 1 or Type 2 Diabetes

United States
Jaeb Center for Health Research
Kowa Company, Ltd.

Terminated

PROMINENT-Eye Ancillary Study (Protocol AD)

Diabetic Retinopathy | Diabetic Macular Edema

United States, Canada
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation

Completed

Metformin Therapy for Overweight Adolescents With Type 1 Diabetes

Type 1 Diabetes

United States
Jaeb Center for Health Research
Foundation Fighting Blindness

Recruiting

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants (Uni-Rare)

Retinitis Pigmentosa | Inherited Retinal Degeneration

United States, United Kingdom, France, Brazil, Canada, Finland, Israel, Mexico, Netherlands, Switzerland, Australia
Jaeb Center for Health Research
Foundation Fighting Blindness

Active, not recruiting

Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS)

Eye Diseases | Retinitis Pigmentosa

United States, Israel, Finland, Canada, France, Germany, Netherlands
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Recruiting

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

Type1diabetes

United States
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Completed

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Diabetes Mellitus, Type 1

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Evaluation of Vitrectomy for Diabetic Macular Edema (Vitrectomy-D)

Diabetic Retinopathy | Diabetic Macular Edema

United States
Jaeb Center for Health Research
JDRF Artificial Pancreas Project

Completed

Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 Diabetes

Type 1 Diabetes

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema (Laser)

Diabetic Macular Edema
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) (Bevacizumab)

Diabetic Retinopathy

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia (ATS14)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old (ATS13)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Full-time Bangerter Filters Versus Part-time Daily Patching for Moderate Amblyopia in Children (ATS10)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Increasing Patching for Amblyopia in Children 3 to < 8 Years Old (ATS15)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds (ATS9)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Levodopa for the Treatment of Residual Amblyopia (ATS17)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Daily Atropine Versus Weekend Atropine

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old (ATS6)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old

Amblyopia

United States
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Recruiting

A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes (2IQP)

Type 2 Diabetes Treated With Insulin

United States, Canada
Emory University
Jaeb Center for Health Research; Insulet Corporation

Completed

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Diabetes Mellitus

United States
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Completed

Control-IQ Technology in Individuals With Type 2 Diabetes (2IQ)

Type 2 Diabetes Treated With Insulin

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old (ATS16)

Amblyopia

United States
Jaeb Center for Health Research
JDRF Artificial Pancreas Project

Completed

Continuous Glucose Sensor Profiles in Non-Diabetic Subjects

Healthy Subjects Without Type 1 Diabetes

United States
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Completed

Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study

Diabetes Mellitus | Type 1 Diabetes | Insulin Pump

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema (Peribulbar)

Diabetic Macular Edema
Jaeb Center for Health Research
National Eye Institute (NEI)

Terminated

Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia (ATS12)

Amblyopia

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Terminated

Combined Patching-Atropine for Residual Amblyopia (ATS11)

Amblyopia

United States

Clinical Trials Sponsored by Jaeb Center for Health Research

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations